[Treatment of relapsed and refractory acute lymphocytic leukemia by modified CAG regimen].
作者信息
Huang Hao, Liu Li'na, Liu Yuzhang, Lin Quande, Zhang Qinglan, Yu Fengkuan, Song Yongping, Fang Baijun
机构信息
Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):340-2. doi: 10.3760/cma.j.issn.0253-2727.2016.04.019.
Abstract
摘要
相似文献
1
[Treatment of relapsed and refractory acute lymphocytic leukemia by modified CAG regimen].
Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):340-2. doi: 10.3760/cma.j.issn.0253-2727.2016.04.019.
2
Salvage therapy with decitabine in combination with granulocyte colony-stimulating factor, low-dose cytarabine, and aclarubicin in patients with refractory or relapsed early T-cell precursor acute lymphoblastic leukemia.
Hematol Oncol. 2020 Dec;38(5):834-837. doi: 10.1002/hon.2783. Epub 2020 Aug 14.
3
Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
Leuk Res. 2015 Mar;39(3):323-8. doi: 10.1016/j.leukres.2015.01.003. Epub 2015 Jan 16.
4
Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
Leuk Res. 2015 Aug;39(8):805-11. doi: 10.1016/j.leukres.2015.04.006. Epub 2015 Apr 20.
5
Increasing the dose of aclarubicin in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) can safely and effectively treat relapsed or refractory acute myeloid leukemia.
Int J Hematol. 2014;99(5):603-8. doi: 10.1007/s12185-014-1528-8. Epub 2014 Mar 13.
6
Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients.
Hematol Oncol. 2013 Dec;31(4):206-12. doi: 10.1002/hon.2051. Epub 2013 Apr 25.
7
Cladribine with Granulocyte Colony-Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study.
Oncologist. 2020 Nov;25(11):e1663-e1670. doi: 10.1634/theoncologist.2020-0818. Epub 2020 Sep 21.
8
Cytarabine, aclarubicin and granulocyte colony-stimulating factor regimen represents an effective and safe salvage regimen for patients with acute myeloid leukemia refractory to first course of induction chemotherapy.
Leuk Lymphoma. 2013 Nov;54(11):2452-7. doi: 10.3109/10428194.2013.776679. Epub 2013 Apr 2.
9
[Efficacy analysis of CAG priming regimen combined with talidomide, interferon and interleukin 2 as the induction therapy for relapsed refractory acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):334-6. doi: 10.3760/cma.j.issn.0253-2727.2016.04.017.
10
[Comparative evaluation of CHAG and CAG priming regimen for treatment of refractory and relapsed acute myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):484-6.
本文引用的文献
1
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
J Clin Oncol. 2010 Aug 10;28(23):3730-8. doi: 10.1200/JCO.2010.28.8852. Epub 2010 Jul 12.
2
Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia.
Leuk Lymphoma. 2010 Jan;51(1):61-5. doi: 10.3109/10428190903388376.
3
Evolving paradigms in the therapy of Philadelphia-chromosome-negative acute lymphoblastic leukemia in adults.
Hematology Am Soc Hematol Educ Program. 2009:362-70. doi: 10.1182/asheducation-2009.1.362.
4
Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.
J Clin Oncol. 2009 Feb 20;27(6):911-8. doi: 10.1200/JCO.2008.18.6916. Epub 2009 Jan 5.
5
[Mechanism of CAG regimen eliminating T-cell acute lymphoblastic leukemia A3 cell line].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1279-82.
6
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
Cancer. 2006 Jan 1;106(1):120-7. doi: 10.1002/cncr.21595.
7
Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes.
Br J Haematol. 2002 Jul;118(1):296-304. doi: 10.1046/j.1365-2141.2002.03574.x.
8
Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells.
Exp Hematol. 1999 Feb;27(2):259-65. doi: 10.1016/s0301-472x(98)00041-1.
9
Involvement of granulocyte colony-stimulating factor in proliferation of adult T-cell leukemia cells.
Leuk Lymphoma. 1998 Oct;31(3-4):295-304. doi: 10.3109/10428199809059222.
10
Constitutive expression of granulocyte-colony stimulating factor receptor on a human B-lymphoblastoid cell line.
Br J Haematol. 1996 Aug;94(2):250-7. doi: 10.1046/j.1365-2141.1966.d01-1806.x.
Zotero 插件